March 2021

Fierce Pharma Asia

Pfizer’s China biosim retreat; WuXi Bio’s buying spree; Fujifilm’s $2B plant

GMA News

A Philippine Food and Drug Administration official on Saturday said the AstraZeneca vaccine that arrived in the country was not from the same batch that have reportedly caused blood clots in some European countries.

Manila Bulletin

The Food and Drug Administration (FDA) confirmed that China’s pharmaceutical firm Sinopharm has already submitted an application for emergency use authorization for its coronavirus disease (COVID-19) vaccine.

The Jakarta Post

We are optimistic for 2021, especially seeing that the market and the government is on the move. The first half of the year will be better than last year, but the industry will not be fully recovered yet. However, we see that recovery can happen in the second half of the year, especially if the vaccination process can take less than 18 months.

Manila Bulletin

It’s been nearly a year since the COVID-19 pandemic started. Despite the imminent distribution of the vaccine in the country, the Philippines remains under quarantine as the government believes that the threat of the viral disease still persists.